| #390 |
Lawrence A. Wolfe |
Glaxo Group Limited |
1 |
| #390 |
Nancy Niconovich |
Lg Life Sciences |
1 |
| #390 |
Lynn McCloskey |
Lg Life Sciences |
1 |
| #390 |
Stephen Rittenhouse |
Lg Life Sciences |
1 |
| #390 |
Emile P. Lemay, III |
Diversified Products |
1 |
| #390 |
Madeline Diane Rogers |
Podimetrics |
1 |
| #390 |
Rachel Flora Xoconostle |
Merck |
1 |
| #390 |
Minghua Gu |
Adolor |
1 |
| #390 |
Judith A. Cadmus |
— |
1 |
| #390 |
Marty Low |
Aramark |
1 |
| #390 |
John J. Mallee |
Merck |
1 |
| #390 |
Kang Yan |
Smithkline Beecham Limited |
1 |
| #390 |
Gwynneth M. Edwards |
Merck |
1 |
| #390 |
John D. Stong |
Merck |
1 |
| #390 |
Geoffrey D'Netto |
Aventis Pharmaceuticals Products |
1 |
| #390 |
Tong Li |
Smithkline Beeacham P.L.C. |
1 |
| #390 |
Pat Filippini |
— |
1 |
| #390 |
Stephen D. Thompson |
Rohm And Haas |
1 |
| #390 |
Anthony Turchi |
BOE |
1 |
| #390 |
Gordon Lee Scheetz, Jr. |
— |
1 |
| #390 |
James F. Callahan |
Smithkline Beecham Limited |
1 |
| #390 |
Shilu Wu |
Merck |
1 |
| #390 |
Gina E. Scheetz |
— |
1 |
| #390 |
Steven G. Cherry |
— |
1 |
| #390 |
Stephen R. Northup |
— |
1 |
| #390 |
Robert John Corry |
Lockheed Martin |
1 |
| #390 |
Marcia V. Fournier |
— |
1 |
| #390 |
Bijoyesh Mookerjee |
Five Prime Therapeutics |
1 |
| #390 |
Joelle L. Burgess |
Smithkline Beecham Limited |
1 |
| #390 |
Ronald W. Godlewski |
— |
1 |